ANDREA PLACE: Open Payments
NPI 1467024455 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,496 in 84 payments from 23 companies in 2025. Trend: 2023 $1,527 · 2024 $1,642 · 2025 $1,496
Food & beverage: $1,496
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $256 |
| AstraZeneca Pharmaceuticals LP | 6 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $141 |
| PFIZER INC. | 6 | $115 |
| Novo Nordisk Inc | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 3 | $61 |
| Dexcom, Inc. | 3 | $56 |
Products named: Kerendia, AIRSUPRA, REXULTI, VRAYLAR, UBRELVY, CAPLYTA, Wegovy, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
